Bulletin
Investor Alert

Turning Point Therapeutics Inc.

NAS: TPTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 16, 2022, 4:47 p.m.

/zigman2/quotes/211319679/composite

$

75.99

Change

-0.02 -0.03%

Volume

Volume 359,395

Quotes are delayed by 20 min

/zigman2/quotes/211319679/composite

Today's close

$ 75.49

$ 76.01

Change

+0.52 +0.69%

Day low

Day high

$75.98

$76.01

Open

52 week low

52 week high

$23.77

$82.20

Open

Annual Financials for Turning Point Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue ---25M30.83M
Cost of Goods Sold (COGS) incl. D&A 52,000138,0001.58M-3.97M
COGS excluding D&A -----
Depreciation & Amortization Expense 52,000138,0001.58M2.39M3.97M
Depreciation 52,000138,0001.58M2.39M3.97M
Amortization of Intangibles -----
Gross Income (52,000)(138,000)(1.58M)-26.86M
20172018201920202021 5-year trend
SG&A Expense 16.68M25.5M76.15M151.84M264.86M
Research & Development 15.24M21.06M57.45M112.54M191.77M
Other SG&A 1.44M4.44M18.69M39.31M-
Other Operating Expense -----
Unusual Expense ---32.6M-
EBIT after Unusual Expense ---(161.84M)-
Non Operating Income/Expense -----
Non-Operating Interest Income 136,000856,0005.59M4.54M1.45M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (16.59M)(24.78M)(72.13M)(157.29M)(236.55M)
Income Tax 1,0001,000---
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (16.59M)(24.79M)(72.13M)(157.29M)(236.55M)
Minority Interest Expense -----
Net Income (16.59M)(24.79M)(72.13M)(157.29M)(236.55M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (16.59M)(24.79M)(72.13M)(157.29M)(236.55M)
Preferred Dividends -----
Net Income Available to Common (16.59M)(24.79M)(72.13M)(157.29M)(236.55M)
EPS (Basic) (0.53)(0.80)(2.99)(3.85)(4.80)
Basic Shares Outstanding 31.04M31.04M24.12M40.84M49.26M
EPS (Diluted) (0.53)(0.80)(2.99)(3.85)(4.80)
Diluted Shares Outstanding 31.04M31.04M24.12M40.84M49.26M
EBITDA (16.68M)(25.5M)(76.15M)(126.84M)(234.03M)
Link to MarketWatch's Slice.